Bridging the Gap in Cancer Research

Big Ten Cancer Research Consortium

The Big Ten Cancer Research Consortium Diversity Committee joins researchers, industry collaborators, and patient advocates to discuss strategic priorities and practices that foster growth, learning, and change toward a more equitable environment for clinical trial participation. read less
Health & FitnessHealth & Fitness
Start Here
Addressing barriers to diversity in clinical trial enrollment
Dec 6 2023
Addressing barriers to diversity in clinical trial enrollment
Dr. Ryan Nguyen, a physician and researcher at the University of Illinois Cancer Center in Chicago, joins our hosts, Dr. Craig Cole of Michigan State University, Dr. Coral Omene of Rutgers University, and Dr. Monika Joshi of Penn State University, for an in-depth conversation on diversity in clinical trials. The group discusses a range of topics including barriers to equitable enrollment in clinical trials, the role of the FDA in promoting more diverse clinical trial enrollment, the role of precision oncology for diverse populations, findings from a clinical study on enrollment in trials leading to FDA approvals in breast cancer, community engagement in clinical trials, and the impact of lung cancer screening.Learn more about the Big Ten Cancer Research Consortium Diversity Committee: https://bigtencrc.org/clinical-research/diversity/About the Big Ten Cancer Research Consortium: The Big Ten cancer centers united to transform the conduct of cancer research through collaborative clinical trials and observational studies that seek to improve the lives of cancer patients in the diverse communities we serve by leveraging the scientific and clinical expertise of Big Ten universities. The Big Ten Cancer Research Consortium creates a unique team research culture to drive science rapidly from ideas to treatment and prevention. Within this innovative environment, today’s research leaders collaborate with and mentor the research leaders of tomorrow.About the Big Ten Conference: The Big Ten Conference is an association of world-class universities whose member institutions share a common mission of research, graduate, professional and undergraduate teaching and public service. Founded in 1896, the Big Ten has sustained a comprehensive set of shared practices and policies that enforce the priority of academics in the lives of students competing in intercollegiate athletics and emphasize the values of integrity, fairness and competitiveness. The broad-based programs of the 14 Big Ten institutions will provide over $200 million in direct financial support to more than 9,800 students for more than 11,000 participation opportunities on 350 teams in 42 different sports. The Big Ten sponsors 28 official conference sports, 14 for men and 14 for women, including the addition of men’s ice hockey and men’s and women’s lacrosse since 2013. For more information, visit www.bigten.org.

Episodes

Addressing barriers to diversity in clinical trial enrollment
Dec 6 2023
Addressing barriers to diversity in clinical trial enrollment
Dr. Ryan Nguyen, a physician and researcher at the University of Illinois Cancer Center in Chicago, joins our hosts, Dr. Craig Cole of Michigan State University, Dr. Coral Omene of Rutgers University, and Dr. Monika Joshi of Penn State University, for an in-depth conversation on diversity in clinical trials. The group discusses a range of topics including barriers to equitable enrollment in clinical trials, the role of the FDA in promoting more diverse clinical trial enrollment, the role of precision oncology for diverse populations, findings from a clinical study on enrollment in trials leading to FDA approvals in breast cancer, community engagement in clinical trials, and the impact of lung cancer screening.Learn more about the Big Ten Cancer Research Consortium Diversity Committee: https://bigtencrc.org/clinical-research/diversity/About the Big Ten Cancer Research Consortium: The Big Ten cancer centers united to transform the conduct of cancer research through collaborative clinical trials and observational studies that seek to improve the lives of cancer patients in the diverse communities we serve by leveraging the scientific and clinical expertise of Big Ten universities. The Big Ten Cancer Research Consortium creates a unique team research culture to drive science rapidly from ideas to treatment and prevention. Within this innovative environment, today’s research leaders collaborate with and mentor the research leaders of tomorrow.About the Big Ten Conference: The Big Ten Conference is an association of world-class universities whose member institutions share a common mission of research, graduate, professional and undergraduate teaching and public service. Founded in 1896, the Big Ten has sustained a comprehensive set of shared practices and policies that enforce the priority of academics in the lives of students competing in intercollegiate athletics and emphasize the values of integrity, fairness and competitiveness. The broad-based programs of the 14 Big Ten institutions will provide over $200 million in direct financial support to more than 9,800 students for more than 11,000 participation opportunities on 350 teams in 42 different sports. The Big Ten sponsors 28 official conference sports, 14 for men and 14 for women, including the addition of men’s ice hockey and men’s and women’s lacrosse since 2013. For more information, visit www.bigten.org.
Introducing the Big Ten Cancer Research Consortium's Diversity Committee Podcast
Aug 8 2023
Introducing the Big Ten Cancer Research Consortium's Diversity Committee Podcast
Monika Joshi, MD, of Penn State Cancer Institute, Craig Cole, MD, of Michigan State University, and Coral Omene, MD, PhD, of Rutgers Cancer Institute of New Jersey talk about the recently established Diversity Committee within the Big Ten Cancer Research Consortium. During the conversation, the co-chairs discuss the range of diversity-focused initiatives the consortium intends to undertake. They also delved into the significance of ensuring equitable access for patients to participate in clinical trials. Learn more about the Big Ten Cancer Research Consortium Diversity Committee: https://bigtencrc.org/clinical-research/diversity/About the Big Ten Cancer Research Consortium: The Big Ten cancer centers have united to transform the conduct of cancer research through collaborative, hypothesis-driven, highly translational oncology trials that leverage the scientific and clinical expertise of Big Ten universities. The Big Ten Cancer Research Consortium creates a unique team-research culture to drive science rapidly from ideas to treatment-changing paradigms. Within this innovative environment, today’s research leaders collaborate with and mentor the research leaders of tomorrow with the unified goal of improving the lives of all patients with cancer.About the Big Ten Conference: The Big Ten Conference is an association of world-class universities whose member institutions share a common mission of research, graduate, professional and undergraduate teaching and public service. Founded in 1896, the Big Ten has sustained a comprehensive set of shared practices and policies that enforce the priority of academics in the lives of students competing in intercollegiate athletics and emphasize the values of integrity, fairness and competitiveness. The broad-based programs of the 14 Big Ten institutions will provide over $200 million in direct financial support to more than 9,800 students for more than 11,000 participation opportunities on 350 teams in 42 different sports. The Big Ten sponsors 28 official conference sports, 14 for men and 14 for women, including the addition of men’s ice hockey and men’s and women’s lacrosse since 2013. For more information, visit www.bigten.org